Integer Holdings Co. (NYSE:ITGR) Short Interest Down 6.6% in January

Integer Holdings Co. (NYSE:ITGR) was the recipient of a large drop in short interest during the month of January. As of January 31st, there was short interest totalling 2,130,000 shares, a drop of 6.6% from the January 15th total of 2,280,000 shares. Based on an average daily trading volume, of 212,300 shares, the short-interest ratio is currently 10.0 days. Currently, 6.6% of the company’s stock are sold short.

Institutional Trading of Integer

Institutional investors have recently modified their holdings of the business. Capital Research Global Investors raised its holdings in Integer by 16.0% during the 4th quarter. Capital Research Global Investors now owns 1,410,803 shares of the medical equipment provider’s stock valued at $186,960,000 after acquiring an additional 194,895 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Integer by 1.2% in the third quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider’s stock worth $99,408,000 after acquiring an additional 9,421 shares during the period. Loomis Sayles & Co. L P grew its position in shares of Integer by 3.8% in the fourth quarter. Loomis Sayles & Co. L P now owns 558,715 shares of the medical equipment provider’s stock valued at $74,041,000 after purchasing an additional 20,688 shares in the last quarter. Congress Asset Management Co. raised its stake in shares of Integer by 2.0% during the 4th quarter. Congress Asset Management Co. now owns 498,350 shares of the medical equipment provider’s stock valued at $66,041,000 after purchasing an additional 9,565 shares during the period. Finally, Driehaus Capital Management LLC lifted its holdings in Integer by 5.5% during the 4th quarter. Driehaus Capital Management LLC now owns 451,464 shares of the medical equipment provider’s stock worth $59,828,000 after purchasing an additional 23,706 shares in the last quarter. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Integer Stock Performance

NYSE ITGR traded up $2.27 during trading on Monday, hitting $140.94. 201,506 shares of the company’s stock traded hands, compared to its average volume of 220,089. The stock has a market capitalization of $4.73 billion, a price-to-earnings ratio of 43.50, a PEG ratio of 1.79 and a beta of 1.13. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. The business has a 50 day moving average of $137.84 and a 200-day moving average of $131.82. Integer has a 12-month low of $94.56 and a 12-month high of $146.36.

Wall Street Analyst Weigh In

A number of analysts recently commented on ITGR shares. Benchmark lifted their price target on Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, October 21st. Wells Fargo & Company reaffirmed an “overweight” rating and set a $160.00 target price on shares of Integer in a research report on Tuesday, December 3rd. KeyCorp boosted their price target on shares of Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Citigroup raised their price objective on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, December 11th. Finally, Truist Financial boosted their target price on shares of Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $146.56.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.